Brand Name Illumina reagents, kits and consumables (BPA)

The United States Army Medical Research Acquisition Activity (USAMRAA) has published a Notice of Intent (NOI) for a sole source acquisition of Brand Name Illumina reagents, kits, and consumables under a Blanket Purchase Agreement (BPA). The procurement is being conducted on behalf of the Walter Reed Army Institute of Research (WRAIR) and the Armed Forces Research Institute of Medical Sciences (AFRIMS) to support laboratory and medical supply needs in Thailand. This special notice indicates the government's intent to award the contract to Bio-Active Co., Ltd, contingent upon the absence of substantive competing proposals. The solicitation number is PANDHA25P0000028745NOI, and the opportunity falls under the Medical and Surgical Instruments, Equipment, and Supplies product service code category. The notice was posted on January 7, 2026, and represents a formal notification of the sole source procurement action.

The primary objective of this procurement is to secure Illumina sequencing platform-compatible reagents and supplies essential for high-throughput sequencing workflows, including microbial surveillance, viral detection, influenza typing, and gene expression profiling operations. Interested contractors must submit written responses demonstrating comparable capability or more advantageous alternatives within 15 days of publication, with the submission deadline of January 21, 2026. All responses must be sent to john.l.fitzsimmons8.civ@health.mil and must provide clear evidence and documentation that extends beyond a mere request for information. While no specific eligibility restrictions are noted, potential contractors should be able to demonstrate proven capability to supply Illumina-compatible products and services at the required specifications and quality levels. If no substantive competing proposals are received by the deadline, USAMRAA will proceed with the sole source award to Bio-Active Co., Ltd.